AB
VRCA icon

Amalgamated Bank’s Verrica Pharmaceuticals VRCA Stock Holding History

Amalgamated Bank’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-70
Closed – – 3157
2025
Q1 		$0 Hold
70
– – ﹤0.01% 2964
2024
Q4 		$0 Hold
70
– – ﹤0.01% 2982
2024
Q3 		$1K Hold
70
– – ﹤0.01% 2977
2024
Q2 		$5K Hold
70
– – ﹤0.01% 2815
2024
Q1 		$4K Sell
70
-226
-76% -$12.5K ﹤0.01% 2801
2023
Q4 		$22K Sell
296
-21
-7% -$863 ﹤0.01% 2612
2023
Q3 		$12K Hold
317
– – ﹤0.01% 2867
2023
Q2 		$18K Buy
+317
New +$19.2K ﹤0.01% 2802
2022
Q2 		– Sell
-213
Closed -$17K – 3213
2022
Q1 		$17K Buy
+213
New +$17.6K ﹤0.01% 2852

Other funds holding VRCA

CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return